Satyaprakash Nayak
Overview
Explore the profile of Satyaprakash Nayak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nayak S, Wajnrajch M, Korth-Bradley J, Taylor C, Thomas M, Maniatis A, et al.
J Endocr Soc
. 2025 Jan;
9(2):bvaf001.
PMID: 39872400
Context: In patients with GH deficiency (GHD) receiving GH treatment, IGF-1 concentrations are used by physicians to monitor treatment safety and efficacy and guide dosing decisions. Somatrogon is a long-acting...
2.
Nayak S, Borse S, Jha S, Mehta V, Murthy Z, Park T, et al.
J Fluoresc
. 2023 Dec;
35(1):509-520.
PMID: 38109031
Fluorescent copper nanoclusters (Cu NCs) were synthesized by using Withania somnifera (W. somnifera) plant extract as a biotemplate. Aqueous dispersion of W. somnifera-Cu NCs displays intense emission peak at 458 ...
3.
Zhu R, Vora B, Menon S, Younis I, Dwivedi G, Meng Z, et al.
Clin Pharmacol Ther
. 2023 Jul;
114(4):751-767.
PMID: 37393555
Since the 21st Century Cures Act was signed into law in 2016, real-world data (RWD) and real-world evidence (RWE) have attracted great interest from the healthcare ecosystem globally. The potential...
4.
DHaens G, Reinisch W, Lee S, Tarabar D, Louis E, Klopocka M, et al.
Inflamm Bowel Dis
. 2021 Aug;
28(7):1034-1044.
PMID: 34427633
Background: Patients with Crohn's disease (CD) experience intestinal inflammation. Ontamalimab (SHP647), a fully human immunoglobulin G2 monoclonal antibody against mucosal addressin cell adhesion molecule-1, is a potential novel CD treatment....
5.
Nayak S, Tammara B, Harnisch L
Drugs R D
. 2021 May;
21(2):217-229.
PMID: 33993463
Background: Sickle cell disease is an inherited blood disorder with reduced blood-carrying capacity. It is associated with a tendency to form microclots in blood vessels, leading to painful episodes known...
6.
Rogers K, Martin S, Bhattacharya I, Singh R, Nayak S
Clin Transl Sci
. 2020 Aug;
14(1):249-259.
PMID: 32822115
Inflammatory bowel disease (IBD) is a heterogeneic disease with a variety of treatments targeting different mechanisms. A multistate, mechanistic, mathematical model of IBD was developed in part 1 of this...
7.
Rogers K, Martin S, Bhattacharya I, Singh R, Nayak S
Clin Transl Sci
. 2020 Aug;
14(1):239-248.
PMID: 32822108
A mechanistic, multistate, mathematical model of inflammatory bowel disease (IBD) was developed by including key biological mechanisms in blood and gut, including cell differentiation, cytokine production, and clinical biomarkers. The...
8.
Gupta N, Bottino D, Simonsson U, Musante C, Bueters T, Rieger T, et al.
Clin Pharmacol Ther
. 2019 Nov;
107(6):1285-1289.
PMID: 31709519
No abstract available.
9.
Schoemaker R, Nayak S, Harnisch L, Karlsson M
J Pharmacokinet Pharmacodyn
. 2019 Aug;
46(5):473-484.
PMID: 31468269
Intracerebral hemorrhage (ICH) is a form of stroke characterized by uncontrolled bleeding into the parenchyma of the brain. There is no approved therapy for ICH and it is associated with...
10.
Koride S, Nayak S, Banfield C, Peterson M
CPT Pharmacometrics Syst Pharmacol
. 2019 May;
8(7):478-488.
PMID: 31044523
Maintaining platelet homeostasis is important to avoid spontaneous bleeding and organ damage. Thrombopoietin, the primary regulator of platelet production, is affected by and acts in part via Janus kinase (JAK)-signal...